Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,155B 12.37B 11.23B 10.37B 9.36B 17.66B 18.34B 125B 49.43B 624B 46.4B 45.42B 1,970B P/E 2027 *
31.5x
P/E 2028 * 23.7x
Enterprise Value 1,125B 12.04B 10.93B 10.1B 9.11B 17.2B 17.86B 122B 48.13B 607B 45.19B 44.23B 1,918B EV / Sales 2027 *
3.2x
EV / Sales 2028 * 2.81x
Free-Float
68.54%
Yield 2027 *
0.54%
Yield 2028 * 0.6%
1 day+1.19%
1 week+0.13%
Current month+5.01%
1 month+13.76%
3 months+22.87%
6 months+9.41%
Current year+5.98%
1 week 14.6
Extreme 14.605
14.94
1 month 13.02
Extreme 13.015
15.08
Current year 11.36
Extreme 11.36
15.67
1 year 11.36
Extreme 11.36
15.67
3 years 11.36
Extreme 11.36
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2019
Director of Finance/CFO - 31/07/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 12/05/2014
Chairman 65 01/04/2013
Director/Board Member 65 24/10/2018
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+0.13% - - 12.24B
-1.02%-1.11%+38.63%+139.37% 1,275B
-0.79%-0.06%+40.60%+87.33% 680B
-0.42%-0.27%+25.26%+111.93% 521B
-0.76%+1.10%+41.43%+70.96% 389B
-0.25%-2.80%+54.98%+41.43% 356B
-1.83%-0.89%+26.00%+58.48% 305B
-1.65%-0.59%+1.55%+34.52% 287B
-0.62%-1.33%+34.33%+72.96% 250B
+1.77%-0.43%+37.11%+125.50% 208B
Average -0.57%+0.51%+33.32%+82.50% 475B
Weighted average by Cap. -0.87%+0.76%+35.21%+95.95%

Financials

2027 *2028 *
Net sales 351B 3.76B 3.41B 3.15B 2.84B 5.37B 5.58B 38B 15.03B 190B 14.11B 13.81B 599B 393B 4.21B 3.82B 3.53B 3.18B 6.01B 6.24B 42.54B 16.83B 212B 15.79B 15.46B 671B
Net income 36.52B 391M 355M 328M 296M 558M 580M 3.95B 1.56B 19.71B 1.47B 1.44B 62.26B 49.32B 528M 479M 443M 399M 754M 783M 5.33B 2.11B 26.61B 1.98B 1.94B 84.08B
Net Debt -30.25B -324M -294M -272M -245M -462M -480M -3.27B -1.29B -16.32B -1.21B -1.19B -51.58B -49.45B -529M -480M -444M -400M -756M -785M -5.35B -2.12B -26.69B -1.99B -1.94B -84.31B
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
17/11/26 US$14.88 +1.22% 609,005
16/11/26 US$14.70 -0.27% 1,232,011
13/11/26 US$14.74 +0.07% 3,713,807
12/11/26 US$14.73 -0.74% 1,654,035
11/11/26 US$14.84 -0.13% 2,176,818
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,387.00INR
Average target price
1,364.41INR
Spread / Average Target
-1.63%